Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects

European Journal of Heart Failure

Volumn 6, Issue 1, 2004, Pages 29-39

  Kjær, Andreas ^a,b   Appel, Jon ^a   Hildebrandt, Per ^a   Petersen, Claus Leth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Adrenaline; Atrial natriuretic peptide; Brain natriuretic peptide; Catecholamines; Endothelin 1; Exercise; Heart failure; Noradrenaline; Renin; Vasopressins

Indexed keywords

ADRENALIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN 1; NEUROHORMONE; NORADRENALIN;

AGED; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOCRINE FUNCTION; ENZYME ACTIVATION; EXERCISE; FEMALE; HEART FAILURE; HEART RATE; HUMAN; INTERMETHOD COMPARISON; KINETOSOME; MALE; MATHEMATICAL COMPUTING; NEUROENDOCRINE SYSTEM; PATIENT SELECTION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WORKLOAD;

AGED; AGED, 80 AND OVER; ARGININE VASOPRESSIN; CASE-CONTROL STUDIES; ENDOTHELIN-1; EXERCISE; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NATRIURETIC PEPTIDES; NEUROSECRETORY SYSTEMS; NOREPINEPHRINE; RENIN;

EID: 0842304878     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(03)00035-7     Document Type: Article

References (46)

1. Kjaer A., Hesse B. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives. Clin Physiol. 21:(6):2001;661-672.
2. Borg G. Simple rating methods for estimation of perceived exertion. Borg G. Physical Work and Effort. 1976;39-47 Pergamon Press, Oxford.
3. Ben Jonathan N., Porter J.C. A sensitive radioenzymatic assay for dopamine, norepinephrine and epinephrine in plasma and tissue. Endocrinology. 98:(6):1976;1497-1507.
4. Poulsen K., Jorgensen J. An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody. J Clin Endocrinol Metab. 39:(5):1974;816-825.
5. Schutten H.J., Johannessen A.C., Torp-Pedersen C., Sander-Jensen K., Bie P., Warberg J. Central venous pressure - a physiological stimulus for secretion of atrial natriuretic peptide in humans? Acta Physiol Scand. 131:(2):1987;265-272.
6. Kjaer A., Knigge U., Warberg J. Involvement of oxytocin in histamine- and stress-induced ACTH and prolactin secretion. Neuroendocrinology. 61:(6):1995;704-713.
7. Noll F. L-lactate: determination with LDH, GTP and NAD. Bergmeyer H.U. Methods of Enzymatic Analysis. 1974;1475-1477 Verlag Chemie/Academic Press, Weinheim/New York.
8. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 82:(5):1990;1724-1729.
9. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 82:(5):1990;1730-1736.
10. Tikkanen I., Fyhrquist F., Metsarinne K., Leidenius R. Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers. Lancet. 2:(8446):1985;66-69.
11. Nakaoka H., Imataka K., Amano M., Fujii J., Ishibashi M., Yamaji T. Plasma levels of atrial natriuretic factor in patients with congestive heart failure [letter]. N Engl J Med. 313:(14):1985;892-893.
12. Richards A.M., Doughty R., Nicholls M.G., et al. Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. Circulation. 99:(6):1999;786-792.
13. Edwards B.S., Zimmerman R.S., Schwab T.R., Heublein D.M., Burnett J.C. Jr. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circ Res. 62:(2):1988;191-195.
14. Mukoyama M., Nakao K., Saito Y., et al. Increased human brain natriuretic peptide in congestive heart failure [letter]. N Engl J Med. 323:(11):1990;757-758.
15. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 87:(4):1991;1402-1412.
16. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 90:(1):1994;195-203.
17. Yoshimura M., Yasue H., Okumura K., et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation. 87:(2):1993;464-469.
18. Goldsmith S.R., Francis G.S., Cowley A.W.J., Levine T.B., Cohn J.N. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1:(6):1983;1385-1390.
19. Levine T.B., Francis G.S., Goldsmith S.R., Simon A.B., Cohn J.N. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 49:(7):1982;1659-1666.
20. Francis G.S., Cohn J.N., Johnson G., Rector T.S., Goldman S., Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation. 87:(Suppl 6):1993;VI40-VI48.
21. Bayliss J., Norell M., Canepa A.R., Sutton G., Poole W.P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 57:(1):1987;17-22.
22. Cody R.J., Haas G.J., Binkley P.F., Capers Q., Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 85:(2):1992;504-509 [published erratum appears in Circulation 1993 Mar;87(3):1064].
23. Stewart D.J., Cernacek P., Costello K.B., Rouleau J.L. Elevated endothelin-1 in heart failure and loss of normal response to postural change. Circulation. 85:(2):1992;510-517.
24. McMurray J.J., Ray S.G., Abdullah I., Dargie H.J., Morton J.J. Plasma endothelin in chronic heart failure. Circulation. 85:(4):1992;1374-1379.
25. Rodeheffer R.J., Lerman A., Heublein D.M., Burnett J.C. Jr. Increased plasma concentrations of endothelin in congestive heart failure in humans [see comments]. Mayo Clin Proc. 67:(8):1992;719-724.
26. Lerman A., Kubo S.H., Tschumperlin L.K., Burnett J.C. Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation [see comments]. J Am Coll Cardiol. 20:(4):1992;849-853.
27. Cacoub P., Dorent R., Nataf P., et al. Plasma endothelin and pulmonary pressures in patients with congestive heart failure. Am Heart J. 126:(6):1993;1484-1488.
28. Thomas J.A., Marks B.H. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 41:(2):1978;233-243.
29. Viquerat C.E., Daly P., Swedberg K., et al. Endogenous catecholamine levels in chronic heart failure. Relation to the severity of hemodynamic abnormalities. Am J Med. 78:(3):1985;455-460.
30. Cohn J.N., Levine T.B., Olivari M.T., et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 311:(13):1984;819-823.
31. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction [see comments]. Lancet. 351:(9095):1998;9-13.
32. Dutka D.P., Olivotto I., Ward S., et al. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure. Eur Heart J. 16:(9):1995;1223-1230.
33. Steele I.C., McDowell G., Moore A., et al. Responses of atrial natriuretic peptide and brain natriuretic peptide to exercise in patients with chronic heart failure and normal control subjects. Eur J Clin Invest. 27:(4):1997;270-276.
34. Ueyama M., Nishimura H., Kubota J., Kawamura K. Hemodynamic and neurohumoral responses to exercise in patients with congestive heart failure. Jpn Circ J. 57:(5):1993;411-417.
35. Kinugawa T., Ogino K., Kitamura H., et al. Catecholamines, renin-angiotensin-aldosterone system and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure. Am J Med Sci. 312:(3):1996;110-117.
36. Nicholls D.P., Riley M., Elborn J.S., et al. Regulatory peptides in the plasma of patients with chronic cardiac failure at rest and during exercise. Eur Heart J. 13:(10):1992;1399-1404.
37. Ferrari R., Anand I.S., Ceconi C., De G.F., Poole W.P., Harris P. Neuroendocrine response to standing and mild exercise in patients with untreated severe congestive heart failure and chronic constrictive pericarditis. Heart. 76:(1):1996;50-55.
38. Luchner A., Burnett J.C. Jr., Jougasaki M., Hense H.W., Riegger G.A., Schunkert H. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. J Am Coll Cardiol. 32:(7):1998;1839-1844.
39. Kato M., Kinugawa T., Omodani H., et al. Augmented response in plasma atrial natriuretic peptide to dynamic exercise in patients with congestive heart failure. Jpn Circ J. 60:(12):1996;909-916.
40. Kato M., Kinugawa T., Ogino K., et al. Augmented response in plasma brain natriuretic peptide to dynamic exercise in patients with left ventricular dysfunction and congestive heart failure. J Intern Med. 248:(4):2000;309-315.
41. Hasking G.J., Esler M.D., Jennings G.L., Dewar E., Lambert G. Norepinephrine spillover to plasma during steady-state supine bicycle exercise. Comparison of patients with congestive heart failure and normal subjects. Circulation. 78:(3):1988;516-521.
42. Kato M., Kinugawa T., Omodani H., et al. Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure. J Card Fail. 2:(2):1996;103-110.
43. Kinugawa T., Ogino K., Kitamura H., et al. Response of sympathetic nervous system activity to exercise in patients with congestive heart failure. Eur J Clin Invest. 21:(5):1991;542-547.
44. Genth-Zotz S., Zotz R.J., Cobaugh M., et al. Changes of neurohumoral parameters and endothelin-1 in response to exercise in patients with mild to moderate congestive heart failure. Int J Cardiol. 66:(2):1998;137-142.
45. Ishikawa S., Miyauchi T., Ueno M., et al. Abnormal neurohumoral responses to exercise in patients with heart disease: inhibition of an increase in endothelin-1 production during exercise. J Cardiovasc Pharmacol. 31:(Suppl 1):1998;S406-S411.
46. de Groote P., Millaire A., Racadot A., Decoulx E., Ducloux G. Plasma levels of endothelin-1 at rest and after exercise in patients with moderate congestive heart failure. Int J Cardiol. 51:(3):1995;267-272.